Loading...

Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study

PURPOSE: Pseudo-progression (PsPD) is a rare phenomenon observed in <5% of cases of non-small cell lung cancer (NSCLC). This event is challenging for both clinicians and patients. Viable biomarkers to distinguish between PsPD and true progressive disease (TPD) are lacking. The aim of our study wa...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Hazama, Daisuke, Sekiya, Reina, Katsurada, Masahiro, Katsurada, Naoko, Tachihara, Motoko, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6897378/
https://ncbi.nlm.nih.gov/pubmed/31819535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S228138
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!